Kinesiophobia Scale for the Upper Extremity

NCT ID: NCT06485934

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-22

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems.

The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational Group

All of the outcomes will be applied to patients who come to the outpatient clinic due to shoulder problems. Then, 1 week later, participants will be recalled to apply the multidimensional kinesiophobia scale a second time.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Tampa Kinesiophobia Score \>37 points
* Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity
* Mini-Mental State Examination score \>24 points

Exclusion Criteria

* Malignancy,
* Psychiatric drug use,
* Use of painkillers during evaluation periods,
* Those who received physiotherapy before the study (last 6 months),
* Those whose education level is below secondary school level,
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emre Şenocak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emre Şenocak

Research Assistant

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abdurrahman Tanhan, PhD

Role: STUDY_CHAIR

Bitlis Eren University

Zeynep Hoşbay, Associate Professor

Role: STUDY_CHAIR

Biruni University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinic of İstanbul Hand-Microsurgery Rehabilitation

Istanbul, , Turkey (Türkiye)

Site Status NOT_YET_RECRUITING

Clinic of İstanbul Hand-Microsurgery Rehabilitation

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emre Şenocak, PhD

Role: CONTACT

+90 553 569 56 92

Aysel Yıldız Özer, Professor

Role: CONTACT

+90 533 467 44 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ozan Tuncel

Role: primary

+90 531 885 5844

Ozan Tuncel, MsC

Role: backup

+90 533 321 18 32

Ozan Tuncel, Physiotherapist

Role: primary

+905533211832

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/74

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.